Persistent Rough Patch on Palate in Long-Term Inhaled Steroid User
This persistent rough palate lesion is most likely steroid-induced mucosal changes (including potential leukoplakia) from chronic inhaled corticosteroid deposition, and requires immediate direct laryngoscopy and oral cavity examination to exclude malignancy or severe candidiasis before any treatment modifications.
Most Likely Etiology
The chronic use of inhaled and nasal corticosteroids directly causes oropharyngeal mucosal changes that manifest as rough patches, leukoplakia, mucosal thickening, erythema, and granulation tissue 1. These changes result from:
- Chemical laryngopharyngitis from topical steroid deposition in the oropharynx, which creates a spectrum of mucosal findings ranging from mild edema to frank leukoplakia 1
- Increased candidiasis risk, with inhaled corticosteroids causing a 3-5 fold increased risk of oral candidiasis depending on delivery device (metered-dose inhalers carry higher risk than dry-powder inhalers) 2
- Dose-dependent mucosal injury, as oropharyngeal adverse events increase significantly with higher corticosteroid doses regardless of device type 2
Critical Diagnostic Imperative
Direct visualization of the lesion via laryngoscopy and oral examination is mandatory before any empiric treatment 3. This is non-negotiable because:
- A non-healing oral lesion lasting months requires tissue diagnosis to exclude squamous cell carcinoma or premalignant dysplasia 1
- Steroid-induced leukoplakia can mimic malignant lesions and requires biopsy for definitive diagnosis 1
- Esophageal candidiasis can occur even in immunocompetent patients on inhaled steroids, and a palatal lesion may represent extension of more severe disease 4
Specific Examination Findings to Document
When examining this patient, specifically assess for:
- Leukoplakia (white patches that cannot be scraped off), mucosal thickening, erythema, or granulation tissue 1
- Candidal plaques (white patches that can be removed, revealing erythematous base) 2, 5
- Laryngeal involvement including vocal cord edema or thickening, as steroid inhaler laryngitis commonly coexists with oral findings 1
- Concurrent laryngopharyngeal reflux signs, as patients with more severe steroid-induced mucosal findings are more likely to have reflux disease as a contributing factor 1
Management Algorithm
Step 1: Obtain Tissue Diagnosis
- Perform biopsy of the rough patch to exclude malignancy or dysplasia 1
- Culture for Candida species if clinical appearance suggests fungal infection 2, 4
Step 2: If Benign Steroid-Induced Changes Confirmed
- Discontinue or reduce inhaled corticosteroid dose when medically feasible, as resolution only occurs after stopping the causative agent 1
- If asthma control requires continued inhaled steroids, implement risk-reduction strategies:
Step 3: Treat Candidiasis if Present
- Initiate antifungal therapy (fluconazole for 2-4 weeks) if candidiasis confirmed 4
- Consider esophagogastroduodenoscopy if dysphagia or odynophagia present, as esophageal candidiasis can occur even in immunocompetent inhaled steroid users 4
Step 4: Address Laryngopharyngeal Reflux
- Treat concurrent reflux disease if present, as it exacerbates steroid-induced mucosal injury 1
Critical Pitfalls to Avoid
- Never empirically treat without visualization - the American Academy of Otolaryngology explicitly recommends against empiric corticosteroid therapy (or any therapy) for oral/laryngeal symptoms without direct examination 3
- Do not assume benignity - a non-healing lesion lasting months requires tissue diagnosis regardless of steroid use history 1
- Do not overlook systemic immunosuppression - while local steroid effects are most likely, verify immune competence if candidiasis is severe or recurrent 4
- Recognize that longer steroid duration increases risk - duration of inhaled corticosteroid use directly correlates with hoarseness, throat irritation, and mucosal changes 6